United States Attorney David Metcalf announced today that Carlos Sacanell, 59, a resident of Willow Grove and a senior scientist for a manufacturer of health-care products, was sentenced to 24 months in prison and a $5,000 fine for insider trading.

Sacanell was charged by indictment in October 2024. In September 2025, he pleaded guilty to one count of securities fraud (insider trading) and one count of making a false statement to a federal agency.

According to court filings, Sacanell obtained material nonpublic information from his domestic partner, who was an executive at Oak Street Health, about CVS Health Corporation’s acquisition of Oak Street Health in 2023.

According to the announcement, both CVS and Oak Street Health were publicly traded companies on the New York Stock Exchange at the time, with ticker symbols CVS and OSH, respectively.

Sacanell used the material nonpublic information obtained from his domestic partner to trade stock and options in Oak Street Health before the transaction was publicly announced on February 8, 2023, resulting in him obtaining profits of approximately $617,000.

When the defendant was interviewed by the FBI in April 2024, he falsely told agents that he did not obtain from his domestic partner information regarding CVS’s planned acquisition of Oak Street Health before the acquisition was publicly announced on February 8, 2023.

This case was investigated by the FBI and prosecuted by Assistant United States Attorney Francis A. Weber. The Securities and Exchange Commission also charged Sacanell, in a parallel matter.

For all the latest news, follow us on Facebook or sign up for Glenside Local’s “Daily Buzz” newsletter here.